Identification of new therapeutic opportunities for pancreatic cancer

Identification of new therapeutic opportunities for pancreatic cancer

Project details

Pancreatic cancer is one of the most lethal of all cancers. There are few treatment options, with most patients treated with palliative intent. We are interested in screening potential new therapeutics, in order to improve patient outcome.  

In this project we will use a living biobank of patient tumour samples to screen for new drugs that can inhibit the growth characteristics of a tumour. This will be coupled to state-of-the-art imaging platforms to assist with the characterisation of therapeutic responses. 

About our research group

This is a highly collaborative project, taking advantage of the skills developed by a team of scientists with expertise in pancreatic cancer models, clinical pancreatic cancer management, and the development of new therapeutics for clinical use.  

  • The Putoczki laboratory is focused on understanding how soluble molecules called cytokines influence the growth and spread of cancer. 

  • The Lessene laboratory uses medicinal chemistry and chemical biology approaches to develop improved therapies for cancer and other diseases. 

  • The Gibbs laboratory leads translational research efforts in multiple cancer types, including pancreatic cancer. 

The student and project will also benefit from collaborations with the University of Melbourne and Victorian Comprehensive Cancer Centre. 


Dr Tracy Putoczki

Dr Tracy Putoczki in a laboratory
Laboratory Head

Associate Professor Guillaume Lessene

Associate Professor Guillaume Lessene in a laboratory
Associate Professor
Laboratory Head; Leader, New Medicines and Advanced Technologies Theme

Professor Peter Gibbs

Peter Gibbs in his office
Joint Division Head

Project Type: